Indeed, while soluble MMP2 neither activates nor inhibits CTLX CAR T efficacy, membrane-bound MMP2 expression on tumor cells is needed for successful CTLX CAR T targeting of GBM tumors [108]. Here, MMP2 is linked to neoplasm.